News
Synthes to be acquired by Johnson and Johnson in $21bn takeover
Posted on : 30 April 2011
The US healthcare corporation Johnson and Johnson has agreed to buy the Swiss orthopaedic implant manufacturer Synthes in a deal worth $21.3 bn (£13bn). Read more
What's available in Short Stem Hip Replacements
Posted on : 30 April 2011
The quest for bone preservation in hip arthroplasty has lead to the development of femoral implants with relatively short stems. The thinking behind these includes not only the preservation of proximal bone stock but possibly also less stress shielding of the proximal femur, ease of revision, reduction of the risk of thigh pain and to facilitate minimally invasive surgery, particularly when using an anterior approach. As hip resurfacing declines in popularity, it is likely that there will be a corresponding increase in the number of short stem femoral components in use. We?ve had a look at what?s available. Read more
